Motion Sickness Drug Market Dynamics and Analysis by 2031
The Motion Sickness Drug Market is expected to register a CAGR of 3.1% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Treatment Type (Anticholinergics, Antihistamines, Others). The report is segmented by Distribution Channel (Retail Pharmacies, Online Pharmacies, Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Motion Sickness Drug Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Motion Sickness Drug Market Segmentation
Treatment Type- Anticholinergics
- Antihistamines
- Others
- Retail Pharmacies
- Online Pharmacies
- Others
Strategic Insights
Motion Sickness Drug Market Growth Drivers- Tourism and Travel Opportunities: One of the key factors propelling the growth of motion sickness drugs market is the growing travel and tourism business across the globe. There is a rise in the number of people going for air travel, cruises, road trips and other forms of international traveling, resulting to very many cases of motion sickness. This is mainly because airlines, cruise lines, and transportation companies are very keen on the comfort of their clients which includes providing motion sickness management drugs. This has escalated the need for effective medicine for motion sickness disorders.
- The Rise in the Health Challenges Awareness: With the increase in health consciousness around the world, the ailments such as motion sickness are also coming into the limelight. Almost everyone at one time has experienced motion sickness, which is basically when the eyes and ear get signals of movement while the body remains motionless. This has made certain consumers turn to the solutions that the market is providing to solve the problem, especially OTC products and prescription drugs. This transformation is due to the effects of the campaigns and due to the increased urge to self-manage simple disorders.
- Creative Solutions in the Existing Drugs: It would be correct to say that the producers of motion sickness drugs have greatly improved over the years. There has been an improvement from the more simplistic drugs known to guarantee effectiveness at the cost of a strong tendency towards sleep. The emerging popularity of non-sedative medications, skin patches and even herbals is for the people who want something different or easier. The extended range of products has increased the volume of the motion sickness drugs market as it has been designed for different ages and health conditions.
- The Enhanced Acceptability to Patients of Non-Sedating Drugs: A noteworthy development in the motion sickness drugs market is increased acceptance of non-drowsy or less drowsy medications. Older therapies such as dimenhydrinate or diphenhydramine, which are present in many over-the-counter medicines, still have a sedative effect on the patient. However, there is a growing market for additional medications and delivery methods that can relieve symptoms without the associated drowsiness especially among people whose jobs do not allow for such, drivers, students, and long-haul travelers for example.
- Use of Natural and Herbal Remedies: There is a growing market for medicinal products based on plants and this is in accord with the growing acceptability of the products that are regarded as holistic and organic. Apart from ginger and peppermint motion sickness has some wristbands which relieve the condition through acupuncture and are in high demand. In this case, the market is offering solutions that blend traditional systems with natural ones for those who do not want to use medicines.
- New Developments in Medicine: In personalized medicine, pharmaceutical companies pursue the goal of developing the treatment regimen according to every patient. Motion sickness is caused by different genes and sensitivities and it has its own different factors that are triggers for different peoples, hence treatment options have to be more specific. Customized drug therapies or thereby combination therapies could be developed useful in the treatment of diseases with the outmost side effects.
- Development of Combination Therapies: There is an increasing complication in the understanding of motion sickness, together with the myriad of causes for the same, which has made it possible to think of combination therapies. For instance, anti: nausea agents could be combined with other medications such as anti: anxiety or anti: inflammatory drugs in a bid to enhance efficacy. Such therapies would be appropriate for individuals experiencing more than one motion sickness symptom at a time, or who have particular triggers for motion sickness.
- Innovations in Drug Delivery Systems: Another area where the potential for advancement can be tapped is in the area of drug delivery systems that are intended to enhance the efficacy, efficiency and ease of use of the therapies for motion sickness. Patches, gels, and nasal sprays, for instance, have been invented to give patients a form of medication other than that taken by mouth. Such systems are also capable of offering localized therapy and allowing quicker onset of effect. For instance, transdermal patches enable the drug to be released at a constant rate, which is ideal for her clients who travel for long hours.
- Strategic Collaborations and Partnerships: The market of medication against motion sickness creates possibilities for strategic alliances between pharmaceutical companies and manufacturers of wearable devices as well as research establishments. This is useful in the case where there are combinations of drug therapies and non: drug therapies incorporating devices such as motion: sensing technologies. Such collaborations might also result in extensions in regards to the existing limitations of the drugs developed for motion sickness.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Motion Sickness Drug Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Motion Sickness Drug Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Players operating in the market are GlaxoSmithKline plc, Perrigo Company plc, Prestige Consumer Healthcare Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals Inc, Myungmoon Pharm Co. Ltd, Baxter International Inc, CVS Health
North America region dominated the Motion Sickness Drug market in 2023.
The Motion Sickness Drug Market is estimated to witness a CAGR of 3.1% from 202#to 2031
Development of Combination Therapies growth act as a opportunity for growth of the market in forecast period.
The major factors driving the Motion Sickness Drug market are:
1. Tourism and Travel Opportunities
2. The Rise in the Health Challenges Awareness
Retail Pharmacies segment, by distribution channel, dominated the market in 2023.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Motion Sickness Drug Market - By Treatment Type
1.3.2 Motion Sickness Drug Market - By Distribution Channel
1.3.3 Motion Sickness Drug Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MOTION SICKNESS DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MOTION SICKNESS DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MOTION SICKNESS DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. MOTION SICKNESS DRUG - GLOBAL MARKET OVERVIEW
6.2. MOTION SICKNESS DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. MOTION SICKNESS DRUG MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTICHOLINERGICS
7.3.1. Overview
7.3.2. Anticholinergics Market Forecast and Analysis
7.4. ANTIHISTAMINES
7.4.1. Overview
7.4.2. Antihistamines Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. MOTION SICKNESS DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. RETAIL PHARMACIES
8.3.1. Overview
8.3.2. Retail Pharmacies Market Forecast and Analysis
8.4. ONLINE PHARMACIES
8.4.1. Overview
8.4.2. Online Pharmacies Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. MOTION SICKNESS DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Motion Sickness Drug Market Overview
9.1.2 North America Motion Sickness Drug Market Forecasts and Analysis
9.1.3 North America Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Motion Sickness Drug Market
9.1.5.1.1 United States Motion Sickness Drug Market by Treatment Type
9.1.5.1.2 United States Motion Sickness Drug Market by Distribution Channel
9.1.5.2 Canada Motion Sickness Drug Market
9.1.5.2.1 Canada Motion Sickness Drug Market by Treatment Type
9.1.5.2.2 Canada Motion Sickness Drug Market by Distribution Channel
9.1.5.3 Mexico Motion Sickness Drug Market
9.1.5.3.1 Mexico Motion Sickness Drug Market by Treatment Type
9.1.5.3.2 Mexico Motion Sickness Drug Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Motion Sickness Drug Market Overview
9.2.2 Europe Motion Sickness Drug Market Forecasts and Analysis
9.2.3 Europe Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Motion Sickness Drug Market
9.2.5.1.1 Germany Motion Sickness Drug Market by Treatment Type
9.2.5.1.2 Germany Motion Sickness Drug Market by Distribution Channel
9.2.5.2 France Motion Sickness Drug Market
9.2.5.2.1 France Motion Sickness Drug Market by Treatment Type
9.2.5.2.2 France Motion Sickness Drug Market by Distribution Channel
9.2.5.3 Italy Motion Sickness Drug Market
9.2.5.3.1 Italy Motion Sickness Drug Market by Treatment Type
9.2.5.3.2 Italy Motion Sickness Drug Market by Distribution Channel
9.2.5.4 Spain Motion Sickness Drug Market
9.2.5.4.1 Spain Motion Sickness Drug Market by Treatment Type
9.2.5.4.2 Spain Motion Sickness Drug Market by Distribution Channel
9.2.5.5 United Kingdom Motion Sickness Drug Market
9.2.5.5.1 United Kingdom Motion Sickness Drug Market by Treatment Type
9.2.5.5.2 United Kingdom Motion Sickness Drug Market by Distribution Channel
9.2.5.6 Rest of Europe Motion Sickness Drug Market
9.2.5.6.1 Rest of Europe Motion Sickness Drug Market by Treatment Type
9.2.5.6.2 Rest of Europe Motion Sickness Drug Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Motion Sickness Drug Market Overview
9.3.2 Asia-Pacific Motion Sickness Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Motion Sickness Drug Market
9.3.5.1.1 Australia Motion Sickness Drug Market by Treatment Type
9.3.5.1.2 Australia Motion Sickness Drug Market by Distribution Channel
9.3.5.2 China Motion Sickness Drug Market
9.3.5.2.1 China Motion Sickness Drug Market by Treatment Type
9.3.5.2.2 China Motion Sickness Drug Market by Distribution Channel
9.3.5.3 India Motion Sickness Drug Market
9.3.5.3.1 India Motion Sickness Drug Market by Treatment Type
9.3.5.3.2 India Motion Sickness Drug Market by Distribution Channel
9.3.5.4 Japan Motion Sickness Drug Market
9.3.5.4.1 Japan Motion Sickness Drug Market by Treatment Type
9.3.5.4.2 Japan Motion Sickness Drug Market by Distribution Channel
9.3.5.5 South Korea Motion Sickness Drug Market
9.3.5.5.1 South Korea Motion Sickness Drug Market by Treatment Type
9.3.5.5.2 South Korea Motion Sickness Drug Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Motion Sickness Drug Market
9.3.5.6.1 Rest of Asia-Pacific Motion Sickness Drug Market by Treatment Type
9.3.5.6.2 Rest of Asia-Pacific Motion Sickness Drug Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Motion Sickness Drug Market Overview
9.4.2 Middle East and Africa Motion Sickness Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Motion Sickness Drug Market
9.4.5.1.1 South Africa Motion Sickness Drug Market by Treatment Type
9.4.5.1.2 South Africa Motion Sickness Drug Market by Distribution Channel
9.4.5.2 Saudi Arabia Motion Sickness Drug Market
9.4.5.2.1 Saudi Arabia Motion Sickness Drug Market by Treatment Type
9.4.5.2.2 Saudi Arabia Motion Sickness Drug Market by Distribution Channel
9.4.5.3 U.A.E Motion Sickness Drug Market
9.4.5.3.1 U.A.E Motion Sickness Drug Market by Treatment Type
9.4.5.3.2 U.A.E Motion Sickness Drug Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Motion Sickness Drug Market
9.4.5.4.1 Rest of Middle East and Africa Motion Sickness Drug Market by Treatment Type
9.4.5.4.2 Rest of Middle East and Africa Motion Sickness Drug Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Motion Sickness Drug Market Overview
9.5.2 South and Central America Motion Sickness Drug Market Forecasts and Analysis
9.5.3 South and Central America Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Motion Sickness Drug Market
9.5.5.1.1 Brazil Motion Sickness Drug Market by Treatment Type
9.5.5.1.2 Brazil Motion Sickness Drug Market by Distribution Channel
9.5.5.2 Argentina Motion Sickness Drug Market
9.5.5.2.1 Argentina Motion Sickness Drug Market by Treatment Type
9.5.5.2.2 Argentina Motion Sickness Drug Market by Distribution Channel
9.5.5.3 Rest of South and Central America Motion Sickness Drug Market
9.5.5.3.1 Rest of South and Central America Motion Sickness Drug Market by Treatment Type
9.5.5.3.2 Rest of South and Central America Motion Sickness Drug Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MOTION SICKNESS DRUG MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MOTION SICKNESS DRUG MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PERRIGO COMPANY PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PRESTIGE CONSUMER HEALTHCARE INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. WELLSPRING PHARMACEUTICAL CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CALEB PHARMACEUTICALS INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MYUNGMOON PHARM CO. LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BAXTER INTERNATIONAL INC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CVS HEALTH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
* Above given report scope is tentative, and may change during the study process as per the research requirement.
* List of companies provided under ‘Company Profile’ chapter is tentative and may change during the course of the study. This list is customizable as per the client requirements.
* Financial information would be provided only for the public companies.
1. GlaxoSmithKline plc
2. Perrigo Company plc
3. Prestige Consumer Healthcare Inc.
4. WellSpring Pharmaceutical Corporation
5. Caleb Pharmaceuticals Inc
6. Myungmoon Pharm Co. Ltd
7. Baxter International Inc
8. CVS Health
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For